ARIAD Pharmaceuticals
ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M.D. and headquartered in Cambridge, Massachusetts. ARIAD engaged in the discovery, development, and commercialization of medicines for cancer patients. In January 2017, Takeda announced it would acquire ARIAD for $5.2 billion, expanding the company's oncology and hematology business. On February 16, 2017, Takeda Pharmaceuticals, Ltd. announced it had completed its acquisition of ARIAD and incorporated ARIAD into Takeda Oncology.
institution
Wikipage redirect
ARIAD Pharmaceuticals, Inc.Apricus BiosciencesAriad PharmaceuticalsAriad Pharmaceuticals, Inc. v. Eli Lilly & Co.BB BiotechBcr-Abl tyrosine-kinase inhibitorBrigatinibDavid BlechGerald CrabtreeHarvey BergerI. Elaine AllenJoan BruggeList of drugs granted breakthrough therapy designationList of pharmaceutical companiesPonatinibProtein kinase inhibitorRidaforolimusStuart SchreiberTakeda_Pharmaceutical_CompanyTargeted molecular therapy for neuroblastomaThe Blech Effect
Link from a Wikipage to another Wikipage
primaryTopic
ARIAD Pharmaceuticals
ARIAD Pharmaceuticals, Inc. was an American oncology company, now part of Takeda Oncology, which was founded in 1991 by Harvey J. Berger, M.D. and headquartered in Cambridge, Massachusetts. ARIAD engaged in the discovery, development, and commercialization of medicines for cancer patients. In January 2017, Takeda announced it would acquire ARIAD for $5.2 billion, expanding the company's oncology and hematology business. On February 16, 2017, Takeda Pharmaceuticals, Ltd. announced it had completed its acquisition of ARIAD and incorporated ARIAD into Takeda Oncology.
has abstract
ARIAD Pharmaceuticals, Inc. wa ...... ed ARIAD into Takeda Oncology.
@en
assets ($)
fate
Merged withTakeda Pharmaceuticals
@en
founding year
key person
number of employees
revenue ($)
type
Link from a Wikipage to an external page
Wikipage page ID
20,737,471
page length (characters) of wiki page
Wikipage revision ID
1,019,615,676
Link from a Wikipage to another Wikipage
assets
fate
Merged with Takeda Pharmaceuticals
@en
foundation
homepage
key people
Alex Denner,
@en
Chairman of the Board
@en
Ed Fitzgerald,
@en
Founder, chairman, and CEO Emeritus
@en
Harvey Berger,
@en
Marty Duvall,
@en
President of Research and Development and Chief Scientific Officer
@en
Timothy P. Clackson,
@en
logo
@en
logo size
name
ARIAD Pharmaceuticals, Inc.
@en
net income
US$ million
@en
num employees
operating income
US$ million
@en
products
revenue
traded as
NASDAQ:ARIA
@en
type
wikiPageUsesTemplate
subject
comment
ARIAD Pharmaceuticals, Inc. wa ...... ed ARIAD into Takeda Oncology.
@en
label
ARIAD Pharmaceuticals
@en
closeMatch
wasDerivedFrom
homepage
isPrimaryTopicOf
name
ARIAD Pharmaceuticals, Inc.
@en